PATENT CLAIM ANALYSIS

Application Number: 16155861
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["514", "275000"]

Abstract:
The present disclosure relates to a 2,4-disubstituted pyrimidine derivative and the use thereof as a therapeutically effective cyclin-dependent kinase (CDK) inhibitor. In particular, the present disclosure relates to the use of a new 2,4-disubstituted pyrimidine derivatives shown in formula (I) and a pharmaceutical composition thereof as a selective CDK4/6 inhibitor in preventing or treating diseases related to CDK4/6.

Claim (Index 5):
Use of the 2,4-disubstituted pyrimidine derivative and a pharmaceutically acceptable salt thereof according to any of  claims 1  as a CDK4/6 inhibitor in preventing or treating diseases related to CDK4/6.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 97.0
- Lexical Diversity: 1.54762
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16155867', '15764884', '15328813', '12843494', '11690305']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7504013778516949
- 35 USC 102 Novelty (BERT): 0.5300783788988961
- Combined Prediction Score: 0.728369077956415
- Mean Citation Score: 279.08915
- Max Citation Score: 322.41934
- Similarity Product: 228.70104502429484

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test